Gilliam Joseph E
Reporting owner on Forms 3, 4 and 5, CIK 1705850.
Gilliam Joseph E reported on 2 issuers in 4 filings, the latest a Form 4 filed 2026-11-18.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| GKOS · GLAUKOS CorpCIK 1192448 | officer (PRESIDENT & COO) | 3 | 2026-11-18 |
| TXG · 10x Genomics, Inc.CIK 1770787 | director | 1 | 2026-11-06 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| GKOS · GLAUKOS CorpCommon Stock | 2026-11-16 | M exercised | +82 | $69.3 | 71,684 | Form 4 |
| GKOS · GLAUKOS CorpCommon Stock | 2026-11-16 | M exercised | +100 | $48.46 | 71,784 | Form 4 |
| GKOS · GLAUKOS CorpCommon Stock | 2026-11-16 | M exercised | +200 | $55.18 | 71,984 | Form 4 |
| GKOS · GLAUKOS CorpCommon Stock | 2026-11-16 | M exercised | +279 | $55.18 | 72,263 | Form 4 |
| GKOS · GLAUKOS CorpCommon Stock | 2026-11-16 | M exercised | +200 | $48.46 | 72,463 | Form 4 |
| GKOS · GLAUKOS CorpCommon Stock | 2026-11-16 | S sold | -861 | $250 | 71,602 | Form 4 |
| GKOS · GLAUKOS CorpStock Option (Right to Buy), derivative | 2026-11-16 | M exercised | -82 | $0 | 743 | Form 4 |
| GKOS · GLAUKOS CorpStock Option (Right to Buy), derivative | 2026-11-16 | M exercised | -100 | $0 | 19,151 | Form 4 |
| GKOS · GLAUKOS CorpStock Option (Right to Buy), derivative | 2026-11-16 | M exercised | -200 | $0 | 19,051 | Form 4 |
| GKOS · GLAUKOS CorpStock Option (Right to Buy), derivative | 2026-11-16 | M exercised | -200 | $0 | 21,668 | Form 4 |
| GKOS · GLAUKOS CorpStock Option (Right to Buy), derivative | 2026-11-16 | M exercised | -279 | $0 | 35,004 | Form 4 |
| GKOS · GLAUKOS CorpCommon Stock | 2026-11-12 | M exercised | +2,475 | $69.3 | 74,077 | Form 4 |
| GKOS · GLAUKOS CorpCommon Stock | 2026-11-12 | M exercised | +7,500 | $48.46 | 81,577 | Form 4 |
| GKOS · GLAUKOS CorpCommon Stock | 2026-11-12 | M exercised | +11,250 | $55.18 | 92,827 | Form 4 |
| GKOS · GLAUKOS CorpCommon Stock | 2026-11-12 | M exercised | +16,192 | $55.18 | 109,019 | Form 4 |
| GKOS · GLAUKOS CorpCommon Stock | 2026-11-12 | M exercised | +7,500 | $48.46 | 116,519 | Form 4 |
| GKOS · GLAUKOS CorpCommon Stock | 2026-11-12 | S sold | -2,402 | $243.41 | 114,117 | Form 4 |
| GKOS · GLAUKOS CorpCommon Stock | 2026-11-12 | S sold | -3,700 | $244.49 | 110,417 | Form 4 |
| GKOS · GLAUKOS CorpCommon Stock | 2026-11-12 | S sold | -8,015 | $245.77 | 102,402 | Form 4 |
| GKOS · GLAUKOS CorpCommon Stock | 2026-11-12 | S sold | -18,440 | $246.49 | 83,962 | Form 4 |
| GKOS · GLAUKOS CorpCommon Stock | 2026-11-12 | S sold | -12,060 | $247.5 | 71,902 | Form 4 |
| GKOS · GLAUKOS CorpCommon Stock | 2026-11-12 | S sold | -300 | $248.42 | 71,602 | Form 4 |
| GKOS · GLAUKOS CorpStock Option (Right to Buy), derivative | 2026-11-12 | M exercised | -2,475 | $0 | 825 | Form 4 |
| GKOS · GLAUKOS CorpStock Option (Right to Buy), derivative | 2026-11-12 | M exercised | -7,500 | $0 | 19,251 | Form 4 |
| GKOS · GLAUKOS CorpStock Option (Right to Buy), derivative | 2026-11-12 | M exercised | -7,500 | $0 | 19,251 | Form 4 |
| GKOS · GLAUKOS CorpStock Option (Right to Buy), derivative | 2026-11-12 | M exercised | -11,250 | $0 | 19,463 | Form 4 |
| GKOS · GLAUKOS CorpStock Option (Right to Buy), derivative | 2026-11-12 | M exercised | -16,192 | $0 | 35,283 | Form 4 |
| TXG · 10x Genomics, Inc.Class A Common Stock, holding | 31 | Form 3 | ||||
| GKOS · GLAUKOS CorpCommon Stock | 2024-04-09 | F withheld for tax | -986 | $87.61 | 71,602 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0001193125-26-467432 | GLAUKOS Corp | 2026-11-18 | ||
| Form 4 0001193125-26-464222 | GLAUKOS Corp | 2026-11-16 | ||
| Form 4 0001193125-26-464102 | GLAUKOS Corp | 2026-11-16 | ||
| Form 3 0001610717-26-000448 | 10x Genomics, Inc. | 2026-11-06 |